4//SEC Filing
Fox Christine 4
Accession 0001209191-23-056412
CIK 0000818686other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 7:18 AM ET
Size
6.0 KB
Accession
0001209191-23-056412
Insider Transaction Report
Form 4
Fox Christine
EVP, Head of U.S. Commercial
Transactions
- Award
Restricted Share Units
2023-11-20+253,968→ 253,968 total→ Ordinary Shares (253,968 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on November 20, 2023, with 63,492 vesting on each of November 20, 2024, November 20, 2025, November 20, 2026 and November 20, 2027.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001998173
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 7:18 AM ET
- Size
- 6.0 KB